These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 24741617)

  • 1. Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis.
    Pancione M; Giordano G; Remo A; Febbraro A; Sabatino L; Manfrin E; Ceccarelli M; Colantuoni V
    J Immunol Res; 2014; 2014():686879. PubMed ID: 24741617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
    O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
    Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
    Zhang Y; Davis C; Shah S; Hughes D; Ryan JC; Altomare D; Peña MM
    Mol Carcinog; 2017 Jan; 56(1):272-287. PubMed ID: 27120577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
    Zhang Y; Song J; Zhao Z; Yang M; Chen M; Liu C; Ji J; Zhu D
    Cancer Lett; 2020 Feb; 470():84-94. PubMed ID: 31610266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.
    Giordano G; Febbraro A; Tomaselli E; Sarnicola ML; Parcesepe P; Parente D; Forte N; Fabozzi A; Remo A; Bonetti A; Manfrin E; Ghasemi S; Ceccarelli M; Cerulo L; Bazzoni F; Pancione M
    J Exp Clin Cancer Res; 2015 Oct; 34():108. PubMed ID: 26427914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials.
    Moretto R; Corallo S; Belfiore A; Rossini D; Boccaccino A; Lonardi S; Centonze G; Morano F; Germani MM; Loupakis F; Morelli L; Urbani L; Brich S; Marmorino F; Prisciandaro M; Aprile G; Fassan M; Cillo U; Cattaneo L; Fontanini G; De Braud F; Falcone A; Milione M; Pietrantonio F; Cremolini C
    Eur J Cancer; 2020 Aug; 135():78-88. PubMed ID: 32554314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
    Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
    Front Immunol; 2021; 12():656364. PubMed ID: 34122412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer.
    Wilkinson K; Ng W; Roberts TL; Becker TM; Lim SH; Chua W; Lee CS
    J Clin Pathol; 2021 Oct; 74(10):625-634. PubMed ID: 33753562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases.
    Ham B; Wang N; D'Costa Z; Fernandez MC; Bourdeau F; Auguste P; Illemann M; Eefsen RL; Høyer-Hansen G; Vainer B; Evrard M; Gao ZH; Brodt P
    Cancer Res; 2015 Dec; 75(24):5235-47. PubMed ID: 26483205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty change of the liver microenvironment influences the metastatic potential of colorectal cancer.
    Masaki S; Hashimoto Y; Kunisho S; Kimoto A; Kitadai Y
    Int J Exp Pathol; 2020 Oct; 101(5):162-170. PubMed ID: 32783302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Innate Immunity on Cancer Cell Stemness.
    Pastò A; Consonni FM; Sica A
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of the β
    Benedicto A; Marquez J; Herrero A; Olaso E; Kolaczkowska E; Arteta B
    BMC Cancer; 2017 Dec; 17(1):827. PubMed ID: 29207960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity.
    Dupaul-Chicoine J; Arabzadeh A; Dagenais M; Douglas T; Champagne C; Morizot A; Rodrigue-Gervais IG; Breton V; Colpitts SL; Beauchemin N; Saleh M
    Immunity; 2015 Oct; 43(4):751-63. PubMed ID: 26384545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment.
    Shaler CR; Tun-Abraham ME; Skaro AI; Khazaie K; Corbett AJ; Mele T; Hernandez-Alejandro R; Haeryfar SMM
    Cancer Immunol Immunother; 2017 Dec; 66(12):1563-1575. PubMed ID: 28798979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive Myeloid Cells Shape the Tumor Immune Microenvironment.
    Xiong J; Wang H; Wang Q
    Adv Biol (Weinh); 2021 Mar; 5(3):e1900311. PubMed ID: 33729699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.
    Mohme M; Riethdorf S; Pantel K
    Nat Rev Clin Oncol; 2017 Mar; 14(3):155-167. PubMed ID: 27644321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.